$DVAX

Organon (OGN) shares surged 39% following reports of a potential $12 billion merger. The significant increase in stock value signals strong investor optimism regarding the company's future prospects. Analysts suggest that if a merger occurs, it could significantly enhance Organon's market position and resources. However, concerns regarding potential integration challenges and regulatory scrutiny persist. Overall, the market response indicates bullish sentiment among investors, driving up the stock's valuation.